Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SRx Health Solutions (SRXH) Finished Goods (2023 - 2025)

SRx Health Solutions' Finished Goods history spans 3 years, with the latest figure at $1.5 million for Q3 2025.

  • For Q3 2025, Finished Goods fell 54.41% year-over-year to $1.5 million; the TTM value through Sep 2025 reached $1.5 million, down 54.41%, while the annual FY2025 figure was $1.5 million, N/A changed from the prior year.
  • Finished Goods reached $1.5 million in Q3 2025 per SRXH's latest filing, down from $4.6 million in the prior quarter.
  • In the past five years, Finished Goods ranged from a high of $5.5 million in Q4 2023 to a low of $1.5 million in Q3 2025.
  • Average Finished Goods over 3 years is $3.6 million, with a median of $3.6 million recorded in 2024.
  • Peak YoY movement for Finished Goods: tumbled 43.54% in 2024, then tumbled 54.41% in 2025.
  • A 3-year view of Finished Goods shows it stood at $5.5 million in 2023, then crashed by 43.54% to $3.1 million in 2024, then tumbled by 50.52% to $1.5 million in 2025.
  • Per Business Quant, the three most recent readings for SRXH's Finished Goods are $1.5 million (Q3 2025), $4.6 million (Q2 2025), and $3.8 million (Q1 2025).